CHINA PHARMA HOLDINGS, INC. Proceeds from Sale and Maturity of Marketable Securities
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from Sale and Maturity of Marketable Securities of $5.21 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2014-05-15
- CHINA PHARMA HOLDINGS, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2014-03-31 was $5.21M, a 86.33% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2013-03-31 was $38.15M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month |
|---|---|
| 2014-03-31 | $5.21M 10-Q · filed 2014-05-15 |
| 2013-03-31 | $38.15M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |